A new chapter: Galderma's landmark IPO on the SIX Swiss Exchange

On March 22, 2024, Galderma, the global dermatology leader, completed its landmark IPO on the SIX Swiss Exchange, raising CHF 2.3 billion—the largest placement volume in Switzerland since 2017, and one of the largest healthcare IPOs ever. The listing marked a defining milestone for the
company, supported by a best-in-class listing and communications strategy that engaged investors, financial media, employees, and customers, while reaffirming Galderma’s leadership in dermatology and innovation.

Galderma spent three years preparing for the IPO, positioning itself as if it were already public. The Intention to Float announcement generated early enthusiasm, and on the listing day, a LinkedIn Live event—a first for both Galderma and the SIX Swiss Exchange—brought together 200 VIP guests in Zurich and thousands of global stakeholders online. The event celebrated Galderma’s longest-serving employee, who represented the dedication of the entire team, and featured a presentation from the CEO that leveraged ChatGPT to showcase the company’s forward-thinking approach. Galderma also distributed replica Swiss cowbells to key offices worldwide, honoring Swiss traditions. The IPO generated over 2,000 media mentions, reaching an estimated 5.2 billion people globally and 3.3 million social media users, with 22,300 engagements. Key outlets like The Financial Times, Wall Street Journal, and Bloomberg highlighted Galderma’s role in revitalizing the European IPO market. This campaign redefined how IPOs are communicated and celebrated in Switzerland, blending tradition and innovation to inspire stakeholders and set a new standard for corporate storytelling.